314140 — RP Bio lnc Balance Sheet
0.000.00%
- KR₩67bn
- KR₩84bn
- KR₩151bn
- 65
- 61
- 39
- 58
Annual balance sheet for RP Bio lnc, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 10,914 | 7,368 | 6,269 | 16,816 | 3,208 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 11,387 | 17,000 | 21,433 | 21,705 | 20,349 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 37,250 | 43,192 | 52,272 | 81,043 | 67,714 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 81,783 | 84,991 | 88,970 | 88,727 | 96,975 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 120,679 | 130,447 | 143,737 | 173,158 | 166,218 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 44,201 | 68,300 | 75,451 | 78,630 | 57,496 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 64,635 | 69,412 | 78,810 | 82,021 | 63,471 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 56,045 | 61,035 | 64,927 | 91,137 | 102,747 |
Total Liabilities & Shareholders' Equity | 120,679 | 130,447 | 143,737 | 173,158 | 166,218 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |